Clinical Trial

Effect of Esketamine on Perioperative Negative Emotions in Breast Cancer Surgery Patients With Severe Depression

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This project employs a prospective, randomized, controlled, blinded, dual-center study design to investigate the effects of intraoperative esketamine on perioperative anxiety and depression symptoms in patients with severe depression undergoing breast cancer surgery.
Trial Details
NCT Number NCT07374211
Lead Sponsor Chinese PLA General Hospital
Conditions Depression, Anxiety, S-ketamine, Breast Cancer
Enrollment 242 participants
Start Date 2026-01-18
Primary Completion 2026-01-18 (estimated)
Study Completion 2027-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-28